LAB vs MTD · rev $174.4M vs P/E 27, rev $3.87B
Standard Biotools Inc (LAB) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
LAB currently screens at market cap $317.1M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the LAB and MTD stock pages for the full models.
Not investment advice.